Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SLIRP overlapping transcript 1 (SLIRP-OT1) is annotated as an uncharacterized protein-coding gene in humans (Gene ID: 283579)[5]. It has also been described by alternative names such as C14orf178 and FLJ25976, and its protein product is termed "putative uncharacterized protein SLIRP-OT1" or "uncharacterized protein C14orf178". The gene is defined at the sequence level, but there is no peer-reviewed evidence concerning its molecular function, involvement in specific pathways, or role in disease. There is also no evidence supporting it as a druggable or therapeutic target[3][5]. No drugs, mechanisms, or clinical biomarkers are associated with SLIRP-OT1. If you are seeking information related to the well-studied SLIRP gene (SRA stem-loop interacting RNA binding protein), this is a distinct, functionally characterized RNA-binding protein and nuclear receptor corepressor with mitochondrial and nuclear roles, unlike SLIRP-OT1[4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLIRP overlapping transcript 1 (SLIRP-OT1).